Profound Medical Corp.
PRN.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.73M | -41.12M | -32.34M | -28.20M | -31.53M |
| Total Depreciation and Amortization | 663.00K | 730.00K | 823.00K | 910.00K | 780.00K |
| Total Amortization of Deferred Charges | -136.00K | -136.00K | -136.00K | -136.00K | -- |
| Total Other Non-Cash Items | 4.52M | 3.52M | 2.89M | 2.72M | 3.21M |
| Change in Net Operating Assets | -2.60M | 2.51M | 1.80M | 1.50M | 2.64M |
| Cash from Operations | -37.28M | -34.50M | -26.97M | -23.22M | -24.90M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -813.00K | -1.41M | -2.01M | -2.34M | -2.02M |
| Issuance of Common Stock | 39.21M | 39.21M | 39.21M | 62.15M | 22.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.04M | -3.04M | -3.04M | -4.90M | -1.86M |
| Cash from Financing | 35.36M | 34.77M | 34.17M | 54.91M | 19.06M |
| Foreign Exchange rate Adjustments | -377.00K | 840.00K | -1.95M | -3.00M | -661.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.30M | 1.12M | 5.25M | 28.70M | -6.50M |